Docking-Based Workflow and ADME Prediction of Compounds in Curcuma Longa and Andrographis Paniculata as Polymerase PA-PB1 Inhibitors of Influenza A/H5N1 Virus

    January 2023 in “ Journal of Research in Pharmacy
    Sitti Nur Aidah Lya CITRA, Arfan Arfan, Alrum Armid, La Ode Santiaji Bande, Irnawati IRNAWATI, Muhammad ARBA
    TLDR Compounds from turmeric and bitter show strong potential as antiviral agents against the influenza A virus.
    This study investigates the potential of compounds from turmeric (Curcuma longa) and bitter (Andrographis paniculata) as inhibitors of the polymerase PA-PB1 enzyme in the influenza A/H5N1 virus using molecular docking methods. Seven compounds from C. longa and thirty-four from A. paniculata showed better docking scores than the reference ligand R151785. Notably, compounds from C. longa and A. paniculata achieved docking scores of -9.979 kcal/mol and -13.153 kcal/mol, respectively, indicating strong inhibitory potential. These compounds interacted with key residues of the PA-PB1 enzyme and met criteria for oral drugs based on Lipinski's rules. The best compound from turmeric demonstrated excellent GI absorption, while the best from bitter showed a good safety profile, inhibiting only the CYP3A4 enzyme. The findings suggest these plants have promising antiviral activity against the influenza A virus, warranting further experimental validation.
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results